Autor: |
Mark Stares, Amanda Swan, Kirsten Cumming, Tze-En Ding, James Leach, Cory Stratton, Findlay Thomson, Colin Barrie, Kirsty MacLennan, Sorcha Campbell, Tamasin Evans, Aisha Tufail, Stephen Harrow, Melanie MacKean, Iain Phillips |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
Frontiers in Nutrition, Vol 8 (2021) |
Druh dokumentu: |
article |
ISSN: |
2296-861X |
DOI: |
10.3389/fnut.2021.734735 |
Popis: |
Introduction: Despite significant advances in systemic anticancer therapy (SACT) for non-small cell lung cancer (NSCLC), many patients still fail to respond to treatment or develop treatment resistance. Albumin, a biomarker of systemic inflammation and malnutrition, predicts survival in many cancers. We evaluated the prognostic significance of albumin in patients receiving first-line targeted therapy or immunotherapy-based SACT for metastatic NSCLC.Methods: All patients treated with first-line targeted therapy or immunotherapy-based SACT for metastatic NSCLC at a regional Scottish cancer centre were identified. Serum albumin at pre-treatment, after 12-weeks of treatment, and at the time of progressive disease were recorded. The relationship between albumin (≥ 35g/L v |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|